CycB/CCNB1 Cancer Research Results
CycB/CCNB1, Cyclin B: Click to Expand ⟱
| Source: |
| Type: |
When cyclin B levels are elevated, cells can enter M phase prematurely and strict control over cell division is lost, which is favorable for cancer development.
Cyclin B is a regulatory protein that plays a crucial role in cell cycle progression, particularly in the transition from the G2 phase to mitosis. Its expression levels can significantly impact cancer progression and patient prognosis.
Cyclin B expression is often elevated in various cancers and is generally associated with poor prognosis.
Cyclin B levels:
-Accumulate during S and G2
-Peak at mitotic entry
-Are rapidly destroyed at metaphase–anaphase transition via the APC/C ubiquitin ligase
|
Scientific Papers found: Click to Expand⟱
ROS↑, results showed that FM induces oxidative DNA damage through ROS generation and triggers G2/M phase cell cycle arrest via the Chk1/Cdc25C/CDK1/CCNB1 signaling pathway.
DNAdam↑,
TumCCA↑,
CHK1↝,
CDC25↝,
CDK1↝,
CycB/CCNB1↝,
GSH↓, FM limited the synthesis of glutathione, promoted lipid peroxidation, and facilitated the generation of divalent iron.
lipid-P↑,
Ferroptosis↑, FM induces ferroptosis by inhibiting the p53/xCT/GPX4 signaling pathway.
xCT↓,
P53↓,
GPx4↓,
other↝, FM could induce DNA damage leading to cell cycle arrest and may also induce ferroptosis by regulating glutathione metabolism, thereby intervening in the occurrence and development of HCC
TumCP↓, FM Inhibits the Proliferation of HepG2 Cells
γH2AX↑, results revealed a significant down-expression of H2A.X and an up-expression of γ-H2A.X,
TumCG↓, FM Inhibits Tumor Growth In Vivo
Ki-67↓, FM could downregulate the expression of proliferation markers Ki67 and PCNA, as well as the ferroptosis marker GPX4
PCNA↓,
MMP↓, FM could induce the accumulation of ROS and a decrease in MMP in HepG2 cells in a dose-dependent manner
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 1, lipid-P↑, 1, ROS↑, 1, xCT↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
CDC25↝, 1, MMP↓, 1,
Cell Death(tgid=5) ⓘ
Ferroptosis↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
DNA Damage & Repair(tgid=10) ⓘ
CHK1↝, 1, DNAdam↑, 1, P53↓, 1, PCNA↓, 1, γH2AX↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↝, 1, CycB/CCNB1↝, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCG↓, 1,
Migration(tgid=13) ⓘ
Ki-67↓, 1, TumCP↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 1,
Total Targets: 22
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CycB/CCNB1, Cyclin B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:379 State#:% Dir#:4
wNotes=on sortOrder:rid,rpid
Home Page